Pancreatic Cancer
📧 Sign up to get email alerts when something new happens for Pancreatic Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-01-05Clinical Trial Update: Exploratory Platform Research on Precision Therapy of Advanced Pancreatic Cancer [Phase 2]
This is a Phase 2 exploratory platform study on precision therapy for advanced pancreatic cancer, currently recruiting.
-
CLINICAL_TRIALS research · 2026-01-02Clinical Trial Update: The CCANED-CIPHER Study: Early Cancer Detection and Treatment Response Monitoring Using AI-Based Platelet and Immune Cell Transcriptomic Profiling
This clinical trial update describes the CCANED-CIPHER study, an ongoing investigation using AI-based transcriptomic profiling of platelets …
-
CLINICAL_TRIALS research · 2026-01-02Clinical Trial Update: QL1706+Lenvatinib+AG Regimen as First-line Treatment for Advanced Metastatic Pancreatic Cancer [Phase 2]
A Phase 2 clinical trial evaluating a triple regimen of QL1706, lenvatinib, and the AG regimen (nab-paclitaxel plus gemcitabine) as first-li…
-
CLINICAL_TRIALS research · 2026-01-02Clinical Trial Update: HRS-4642 in Combination With Gemcitabine and Albumin-bound Paclitaxel and Adebrelimab for Neoadjuvant and Adjuvant Treatment of Pancreatic Cancer [Phase 2]
Phase 2 trial evaluating HRS-4642 with gemcitabine, nab-paclitaxel, and adebrelimab for neoadjuvant and adjuvant pancreatic cancer is curren…
-
CLINICAL_TRIALS research · 2025-12-31Clinical Trial Update: Target-specific immunoPET Imaging of Digestive System Carcinoma [NA]
A recruiting clinical trial evaluating a target-specific immunoPET imaging agent for digestive system carcinomas across multiple digestive c…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2025-12-30Clinical Trial Update: A Phase II/III Trial to Evaluate the Efficacy and Safety of Surufatinib Combined With Camrelizumab, Nab-paclitaxel, and Gemcitabine in Metastatic Pancreatic Cancer [Phase 2, Phase 3]
This clinical trial update describes a Phase II/III study evaluating the efficacy and safety of Surufatinib in combination with Camrelizumab…
-
CLINICAL_TRIALS research · 2025-12-29Clinical Trial Update: ImmunoPET Imaging of Pancreatic Cancer [NA]
A clinical trial update indicates an ImmunoPET imaging study for pancreatic cancer is currently recruiting at RenJi Hospital.
-
CLINICAL_TRIALS research · 2025-12-29Clinical Trial Update: PET-imaging of Two Vartumabs in Patients With Solid Tumors [EARLY_Phase 1]
This early-phase PET-imaging trial evaluates two vartumabs in patients with solid tumors and is currently recruiting.
-
CLINICAL_TRIALS research · 2025-12-24Clinical Trial Update: Mutant KRAS G12V-specific TCR Transduced T Cell Therapy for Advanced Pancreatic Cancer [Phase 1, Phase 2]
This clinical trial update reports a Phase 1/2 study of a KRAS G12V-specific T cell receptor-transduced T cell therapy for advanced pancreat…
-
CLINICAL_TRIALS research · 2025-12-24Clinical Trial Update: Tunlametinib + AG + Cetuximab β as First-Line Therapy for Advanced Pancreatic Cancer [Phase 4]
Phase 4 trial planned to evaluate tunlametinib plus AG and Cetuximab beta as first-line therapy for advanced non-resectable pancreatic cance…
-
CLINICAL_TRIALS research · 2025-12-24Clinical Trial Update: Clinical Application of PET Imaging Targeting CLDN18.2 in Malignant Tumors
A clinical trial is evaluating PET imaging targeting CLDN18.2 for detecting malignant tumors, with recruitment ongoing in gastric cancer, pa…
-
CLINICAL_TRIALS research · 2025-12-24Clinical Trial Update: Phase II Study to Evaluate Modified Folfirinox and Stereotactic Body Radiation Therapy in Non-metastatic Unresectable Pancreatic Adenocarcinoma [Phase 2]
This update describes an ongoing Phase II clinical trial at Yale evaluating a modified FOLFIRINOX chemotherapy regimen together with stereot…
-
CLINICAL_TRIALS research · 2025-12-23Clinical Trial Update: A Study of GC203 TIL in PDCA (RJ) [EARLY_Phase 1]
Phase 1 study evaluating GC203 TIL therapy for pancreatic cancer, including pancreatic ductal adenocarcinoma. The trial is currently recruit…
-
CLINICAL_TRIALS research · 2025-12-23Clinical Trial Update: Acupuncture for the Management of Postoperative Pain in Patients With Pancreatic or Colorectal Cancer Undergoing Surgery [NA]
An update on a clinical trial evaluating acupuncture to manage postoperative pain in patients with pancreatic or colorectal cancer undergoin…
-
CLINICAL_TRIALS research · 2025-12-23Clinical Trial Update: A Study of PT0511 in Participants With KRAS Mutated or Amplified Advanced Solid Tumors [Phase 1]
A Phase 1 study evaluating PT0511 in adults with KRAS-mutated or amplified advanced solid tumors, including colorectal cancer, pancreatic ca…
-
CLINICAL_TRIALS research · 2025-12-22Clinical Trial Update: The Cancer Connected Access and Remote Expertise Beyond Walls Program to Provide In-Home Cancer Treatment and Improve Treatment Satisfaction in Cancer Patients Living in the Florida Panhandle and Surrounding Areas [Phase 2]
A Phase 2 clinical trial update describes a program for in-home cancer treatment with remote expert support, currently recruiting for patien…
-
CLINICAL_TRIALS research · 2025-12-19Clinical Trial Update: A Study of Ivaltinostat Plus Capecitabine or Capecitabine in Metastatic Pancreatic Adenocarcinoma [Phase 1, Phase 2]
Ongoing Phase 1/2 clinical trial evaluating Ivaltinostat with Capecitabine (or Capecitabine alone) for metastatic pancreatic adenocarcinoma;…
-
CLINICAL_TRIALS research · 2025-12-19Clinical Trial Update: Whether Control of Serum Uric Acid (SUA) Improves Survival After Pancreatic Cancer
This clinical trial investigates whether controlling serum uric acid improves survival after pancreatic cancer and is currently recruiting.
-
CLINICAL_TRIALS research · 2025-12-19Clinical Trial Update: Pancreatic Cancer Detection Consortium
This Clinical Trial Update describes the Pancreatic Cancer Detection Consortium sponsored by City of Hope Medical Center, currently recruiti…
-
CLINICAL_TRIALS research · 2025-12-17Clinical Trial Update: Palliadelic Treatment to Reduce Psychological Distress in Persons With Advanced Gastrointestinal Cancers [Phase 1]
Phase 1 clinical trial evaluating Palliadelic treatment to reduce psychological distress in people with advanced pancreatic and biliary trac…
-
CLINICAL_TRIALS research · 2025-12-17Clinical Trial Update: RCT of Mobile Apps & FitBit v. Usual Care [NA]
An ongoing randomized trial compares a mobile apps plus FitBit intervention to usual care in patients with pancreatic, gastric, liver, colon…
-
CLINICAL_TRIALS research · 2025-12-17Clinical Trial Update: A Trial to Evaluate Safety and Tolerability of TST001 in Advanced or Metastatic Solid Tumors [Phase 1, Phase 2]
Clinical trial update for TST001 in advanced or metastatic solid tumors (Phase 1/2); the study is currently active and not recruiting.
-
CLINICAL_TRIALS research · 2025-12-17Clinical Trial Update: An Open-Label Study to Enable Continued Treatment Access for Subjects Previously Enrolled in Studies of Ruxolitinib [Phase 2]
An open-label Phase 2 extension study to enable continued access to ruxolitinib for subjects previously enrolled in ruxolitinib trials.
-
CLINICAL_TRIALS research · 2025-12-16Clinical Trial Update: Hyperthermic Intraperitoneal Chemotherapy for the Treatment of Pancreatic Cancer and Peritoneal Metastasis [Phase 2]
Phase 2 clinical trial investigating hyperthermic intraperitoneal chemotherapy (HIPEC) for metastatic pancreatic cancer with peritoneal meta…
-
CLINICAL_TRIALS research · 2025-12-16Clinical Trial Update: TTFields and Chemotherapy in Metastatic Pancreatic Adenocarcinoma (mPDAC) [Phase 1, Phase 2]
A clinical trial update indicates that Tumor Treating Fields (TTFields) combined with chemotherapy is being studied in metastatic pancreatic…